ID   ZN319_HUMAN             Reviewed;         582 AA.
AC   Q9P2F9; Q52LH8;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   15-NOV-2002, sequence version 2.
DT   28-JUN-2023, entry version 179.
DE   RecName: Full=Zinc finger protein 319;
GN   Name=ZNF319; Synonyms=KIAA1388;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-281, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [4]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-130, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-130, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       Q9P2F9; Q9BUH8: BEGAIN; NbExp=5; IntAct=EBI-11993110, EBI-742722;
CC       Q9P2F9; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-11993110, EBI-3867333;
CC       Q9P2F9; Q92997: DVL3; NbExp=3; IntAct=EBI-11993110, EBI-739789;
CC       Q9P2F9; O75791: GRAP2; NbExp=3; IntAct=EBI-11993110, EBI-740418;
CC       Q9P2F9; O76011: KRT34; NbExp=3; IntAct=EBI-11993110, EBI-1047093;
CC       Q9P2F9; Q6A162: KRT40; NbExp=3; IntAct=EBI-11993110, EBI-10171697;
CC       Q9P2F9; P60371: KRTAP10-6; NbExp=3; IntAct=EBI-11993110, EBI-12012928;
CC       Q9P2F9; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-11993110, EBI-10171774;
CC       Q9P2F9; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-11993110, EBI-10172052;
CC       Q9P2F9; Q3SY46: KRTAP13-3; NbExp=3; IntAct=EBI-11993110, EBI-10241252;
CC       Q9P2F9; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-11993110, EBI-22310682;
CC       Q9P2F9; O75928-2: PIAS2; NbExp=3; IntAct=EBI-11993110, EBI-348567;
CC       Q9P2F9; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-11993110, EBI-949255;
CC       Q9P2F9; P78424: POU6F2; NbExp=3; IntAct=EBI-11993110, EBI-12029004;
CC       Q9P2F9; P78317: RNF4; NbExp=5; IntAct=EBI-11993110, EBI-2340927;
CC       Q9P2F9; Q8WV44: TRIM41; NbExp=3; IntAct=EBI-11993110, EBI-725997;
CC       Q9P2F9; Q2TAL6: VWC2; NbExp=3; IntAct=EBI-11993110, EBI-11957238;
CC       Q9P2F9; Q6P1L6: ZNF343; NbExp=3; IntAct=EBI-11993110, EBI-10252492;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92626.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB037809; BAA92626.1; ALT_INIT; mRNA.
DR   EMBL; BC093919; AAH93919.1; -; mRNA.
DR   EMBL; BC101767; AAI01768.1; -; mRNA.
DR   CCDS; CCDS32462.1; -.
DR   RefSeq; NP_065858.1; NM_020807.2.
DR   RefSeq; XP_005256126.1; XM_005256069.3.
DR   AlphaFoldDB; Q9P2F9; -.
DR   SMR; Q9P2F9; -.
DR   BioGRID; 121620; 25.
DR   IntAct; Q9P2F9; 20.
DR   STRING; 9606.ENSP00000299237; -.
DR   iPTMnet; Q9P2F9; -.
DR   PhosphoSitePlus; Q9P2F9; -.
DR   BioMuta; ZNF319; -.
DR   DMDM; 25091755; -.
DR   EPD; Q9P2F9; -.
DR   jPOST; Q9P2F9; -.
DR   MassIVE; Q9P2F9; -.
DR   MaxQB; Q9P2F9; -.
DR   PaxDb; Q9P2F9; -.
DR   PeptideAtlas; Q9P2F9; -.
DR   ProteomicsDB; 83809; -.
DR   Antibodypedia; 29030; 106 antibodies from 20 providers.
DR   DNASU; 57567; -.
DR   Ensembl; ENST00000299237.3; ENSP00000299237.2; ENSG00000166188.3.
DR   GeneID; 57567; -.
DR   KEGG; hsa:57567; -.
DR   MANE-Select; ENST00000299237.3; ENSP00000299237.2; NM_020807.3; NP_065858.1.
DR   UCSC; uc002emx.2; human.
DR   AGR; HGNC:13644; -.
DR   CTD; 57567; -.
DR   DisGeNET; 57567; -.
DR   GeneCards; ZNF319; -.
DR   HGNC; HGNC:13644; ZNF319.
DR   HPA; ENSG00000166188; Low tissue specificity.
DR   neXtProt; NX_Q9P2F9; -.
DR   OpenTargets; ENSG00000166188; -.
DR   PharmGKB; PA134937483; -.
DR   VEuPathDB; HostDB:ENSG00000166188; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000160309; -.
DR   HOGENOM; CLU_002678_44_5_1; -.
DR   InParanoid; Q9P2F9; -.
DR   OMA; QHHSAHT; -.
DR   OrthoDB; 4044100at2759; -.
DR   PhylomeDB; Q9P2F9; -.
DR   TreeFam; TF332615; -.
DR   PathwayCommons; Q9P2F9; -.
DR   SignaLink; Q9P2F9; -.
DR   BioGRID-ORCS; 57567; 18 hits in 1183 CRISPR screens.
DR   ChiTaRS; ZNF319; human.
DR   GenomeRNAi; 57567; -.
DR   Pharos; Q9P2F9; Tdark.
DR   PRO; PR:Q9P2F9; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9P2F9; protein.
DR   Bgee; ENSG00000166188; Expressed in granulocyte and 125 other tissues.
DR   ExpressionAtlas; Q9P2F9; baseline and differential.
DR   Genevisible; Q9P2F9; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 11.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24381:SF393; CHROMATIN-LINKED ADAPTOR FOR MSL PROTEINS, ISOFORM B; 1.
DR   PANTHER; PTHR24381; ZINC FINGER PROTEIN; 1.
DR   Pfam; PF00096; zf-C2H2; 7.
DR   Pfam; PF13465; zf-H2C2_2; 1.
DR   SMART; SM00355; ZnF_C2H2; 14.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 8.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 15.
PE   1: Evidence at protein level;
KW   DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..582
FT                   /note="Zinc finger protein 319"
FT                   /id="PRO_0000047527"
FT   ZN_FING         76..100
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         104..126
FT                   /note="C2H2-type 2; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         132..154
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         202..224
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         230..252
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         258..280
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         287..309
FT                   /note="C2H2-type 7; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         315..337
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         343..365
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         371..393
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         399..421
FT                   /note="C2H2-type 11; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         428..450
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         458..480
FT                   /note="C2H2-type 13; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         486..508
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         514..536
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         542..564
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..39
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          174..198
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..34
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CROSSLNK        130
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
SQ   SEQUENCE   582 AA;  65547 MW;  E2FBD02256BE0A67 CRC64;
     MSESWQQPPQ TQPQQPQPPQ PQHHAEPPPA LAEHTLPPGT AENPLGCAVY GILLQPDPGL
     QPPQHAPLQA AGEPGPKCGV CGHDLAHLSS PHEHQCLAGH DRSFQCTQCL KIFHQATDLL
     EHQCVQAEQK PFVCGVCKMG FSLLTSLAQH HSSHSGLVKC SICEKTYKPA EAAEPATTAA
     PSLPAAPAPS TVTPAEQADK PYSCPICQKP FKHLSELSRH ERIHTGEKPY KCTLCDKSFS
     QSSHLVHHKR THSSERPYKC AVCEKTFKHR SHLVRHMYAH SGEHHLFRCN VCELHFKESS
     ELLQHPCTPS GERPFRCGEC QKAFKRPSDL RQHERTHSAE RPFKCDLCPM GFKQQYALMR
     HRRTHKTEEP FKCGLCEKGF GQPSHLLYHQ HVHTLETLFK CPVCQKGFDQ SAELLRHKCL
     PGAAERPFKC PVCNKAYKRA SALQKHQLAH CAAAEKPLRC TLCERRFFSS SEFVQHRCDP
     AREKPLKCPD CEKRFKYASD LQRHRRVHTG EKPYKCPNCD KAFKQREHLN KHQGVHAREQ
     QFKCVWCGER FLDVALLQEH SAQHSAAAAA AEGAYQVAAC LP
//
